Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element
- PMID: 2170976
- PMCID: PMC54752
- DOI: 10.1073/pnas.87.19.7390
Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element
Abstract
Previous studies suggest that the Epstein-Barr virus nuclear antigen EBNA2 participates in the regulation of the expression of the viral latent membrane protein (LMP). We have used reporter plasmids containing DNA fragments of the 5' flanking region of the LMP gene in cotransfection experiments to analyze the effect of EBNA2 on the activity of the LMP promoter. The results show that the LMP promoter is controlled by positive and negative transcription elements in a DNA fragment that contains the LMP transcription initiation site and 634 base pairs of upstream sequences. The promoter is activated by EBNA2. The region between position -54 and +40 relative to the mRNA cap site contains a positive transcription element that is constitutively active in DG75 cells and independent of EBNA2. The -106 to -54 region contains a negative regulatory element that prevents adjacent positive elements from functioning in the absence of EBNA2. Regulatory sequences between -324 and -144 participate in maintaining a high level of transcription of the LMP promoter after induction with EBNA2. The regulatory elements in the -634 to -54 promoter region have the characteristics of an inducible enhancer, including orientation independence and ability to regulate a heterologous promoter.
Similar articles
-
The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.EMBO J. 1993 Jan;12(1):167-75. doi: 10.1002/j.1460-2075.1993.tb05642.x. EMBO J. 1993. PMID: 8381349 Free PMC article.
-
Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.J Virol. 1994 Nov;68(11):6947-58. doi: 10.1128/JVI.68.11.6947-6958.1994. J Virol. 1994. PMID: 7933076 Free PMC article.
-
The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.Nucleic Acids Res. 1988 Sep 12;16(17):8391-410. doi: 10.1093/nar/16.17.8391. Nucleic Acids Res. 1988. PMID: 2843816 Free PMC article.
-
Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.Virology. 1993 Apr;193(2):774-85. doi: 10.1006/viro.1993.1186. Virology. 1993. PMID: 8384755
-
Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.Immunobiology. 1997 Dec;198(1-3):299-306. doi: 10.1016/s0171-2985(97)80050-2. Immunobiology. 1997. PMID: 9442401 Review.
Cited by
-
Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6550-4. doi: 10.1073/pnas.88.15.6550. Proc Natl Acad Sci U S A. 1991. PMID: 1713681 Free PMC article.
-
Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.J Virol. 2000 Jan;74(1):379-89. doi: 10.1128/jvi.74.1.379-389.2000. J Virol. 2000. PMID: 10590127 Free PMC article.
-
The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.EMBO J. 1993 Jan;12(1):167-75. doi: 10.1002/j.1460-2075.1993.tb05642.x. EMBO J. 1993. PMID: 8381349 Free PMC article.
-
c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10411-6. doi: 10.1073/pnas.93.19.10411. Proc Natl Acad Sci U S A. 1996. PMID: 8816814 Free PMC article.
-
Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.Oncotarget. 2017 Jul 4;8(27):44266-44280. doi: 10.18632/oncotarget.17863. Oncotarget. 2017. PMID: 28574826 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous